Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected

Statistics in Medicine

Volumn 28, Issue 16, 2009, Pages 2116-2146

  Kafadar, Karen ^a   Prorok, Philip C ^b  

^a INDIANA UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bivariate gamma distribution; Clinical duration; HIP trial; Lead time; Periodic screening; Randomized screening trial; Sojourn time

Indexed keywords

ARTICLE; BIVARIATE ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE MODEL; EARLY DIAGNOSIS; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MEDIAN TEST; NONPARAMETRIC TEST; SAMPLING ERROR; SCREENING; STATISTICAL DISTRIBUTION; SURVIVAL; SURVIVAL TIME; BIOMETRY; BREAST TUMOR; EPIDEMIOLOGY; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; TIME;

BIOMETRY; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MASS SCREENING; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLING STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 69149084712     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3601     Document Type: Article

References (40)

1. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963-1986. Johns Hopkins University Press: Baltimore, 1988.
2. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiology Clinics of North America 1992; 30:187-210.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control study. New England Journal of Medicine 1993; 328:1365-1371.
4. Fontana RS. Early detection of lung cancer: the Mayo Lung Project. In Screening for Cancer and Screening for Lung, Bladder, and Oral Cancer, Prorok PC, Miller AB (eds), vol. 78. International Union Against Cancer: Geneva, Switzerland, 1984; 107-122.
5. Aron JL, Prorok PC. An analysis of the mortality effect in a breast cancer screening study. International Journal of Epidemiology 1986; 15:36-43.
6. Kafadar K, Prorok PC. Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials. Statistics in Medicine 2003; 21:83-111.
7. Kafadar K, Prorok PC. Computational methods in medical decision making: to screen or not to screen? Statistics in Medicine 2005; 24:569-581.
8. Morrison AS. Sequential pathogenic components of rates. American Journal of Epidemiology 1979; 109:709-718.
9. Zelen M. Theory of early detection of breast cancer in the general population. In Breast Cancer: Trends in Research and Treatment, Heuson JC, Mattheiem WH, Rozenweig M (eds). Raven Press: New York, 1976; 287-301.
10. Zelen M, Feinleib M. On the theory of screening for chronic diseases. Biometrika 1969; 56:601-613.
11. Wang MC. Length bias. In Encyclopedia of Biostatistics, Armitage P, Colton T (eds). Wiley: New York, 1998.
12. Kalbfleisch JD, Lawless JF, Robinson JA. Methods for the analysis and prediction of warranty claims. Technometrics 1991; 33:273-286.
13. Scheaffer RL. Size-biased sampling. Technometrics 1972; 14:635-644.
14. Schotz WE, Zelen M. Effect of length sampling bias on labeled mitotic index waves. Journal of Theoretical Biology 1971; 32:383-404.
15. Nair VN, Wang PL. Maximum likelihood estimation under a successive sampling discovery model. Technometrics 1989; 31:423-436.
16. Jones MC. Kernel density estimation for length biased data. Biometrika 1991; 78:511-519.
17. Cox DR. Some sampling problems in technology. In New Developments in Survey Sampling, Johnson NL, Smith Jr H (eds). Wiley: New York, 1969; 506-527.
18. Vardi Y. Nonparametric estimation in the presence of length bias. Annals of Statistics 1982; 10:616-620.
19. Horvath L. Estimation from a length-biased distribution. Statistics and Decisions 1984; 3:91-113.
20. Wang MC. Hazards regression analysis for length biased data. Biometrika 1996; 83:343-354.
21. Vardi Y. Multiplicative censoring, renewal processes, deconvolution and decreasing density. Biometrika 1989; 76:751-761.
22. Asgharian M, M'Lan CE, Wolfson DB. Length-biased sampling with right censoring: an unconditional approach. Journal of the American Statistical Association 2002; 97:201-209.
23. Gupta PL, Tripathi RC. Effect of length-biased sampling on the modeling error. Communications in Statistics - Theory and Methods 1990; 19:1483-1491.
24. Cnaan A. Survival models with two phases and length biased sampling. Communications in Statistics - Theory and Methods 1985; 14:861-886.
25. Blumenthal S. Proportional sampling in life-length studies. Technometrics 1967; 9:205-218.
26. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstalh EJ. Screening for lung cancer: a critique of the Mayo lung project. Cancer 1991; 67:1155-1164.
27. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms, Part I. Journal of Surgical Oncology 1995; 60:137-146.
28. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms, Part II. Journal of Surgical Oncology 1996; 61:68-83.
29. Kafadar K, Prorok PC. A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized trials. Statistics in Medicine 1994; 13:569-586.
30. Vardi Y. Empirical distributions in selection bias models. Annals of Statistics 1985; 13:178-203.
31. Gill RD, Vardi Y, Wellner JA. Large sample theory of empirical distributions in biased sampling models. Annals of Statistics 1988; 16:1069-1112.
32. Kafadar K, Prorok PC. Computer simulation experiments of randomized screening trials. Computational Statistics and Data Analysis 1996; 23:263-291.
33. Cox DR, Lewis PAW. The Statistical Analysis of Discrete Time Events. Oxford Press: London, 1972.
34. Chen J, Prorok PC, Graff KM. An age dependent stochastic model of periodic screening: length bias at a prevalence screen. Mathematical Biosciences 1983; 65:93-123.
35. Abramowicz M, Stegun I. Handbook of Mathematical Functions. Dover: New York, 1958.
36. Heltshe S. Quantification of length bias in randomized cancer screening trials. Ph.D. Dissertation, Department of Preventive Medicine and Biometrics, University of Colorado-Denver and Health Sciences Center, 2007.
37. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. Journal of the National Cancer Institute 2000; 91:1490-1499.
38. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. Journal of Urology 1994; 152:1905-1909.
39. Beran R. Minimum Hellinger distance estimates for parametric models. Annals of Statistics 1977; 5:445-463.
40. Jeffrey S. Smoothing Methods in Statistics. Springer: New York, 1996.